Time Restricted Eating for Endometrial Cancer Patients
Feasibility and Acceptability of Time Restricted Eating (TRE) Among Endometrial Cancer Patients: the TREND Study
This study is testing if a special eating schedule called Time Restricted Eating can help women with endometrial cancer improve their health and treatment outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Trial ID | NCT04783467 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of Time Restricted Eating (TRE) in improving metabolic health and prognosis among endometrial cancer patients. It involves a 16-week randomized dietary crossover intervention where participants will alternate between a control diet and a TRE schedule. The study will assess feasibility, fidelity, and acceptability of TRE, with participants receiving prepared meals and following specific eating windows. The research will be conducted at the Huntsman Cancer Hospital Clinics, with a focus on women who are clinically overweight or obese.
Who should consider this trial
Good fit: Ideal candidates are females aged 18 or older, diagnosed with endometrial cancer, and clinically overweight or obese.
Not a fit: Patients with special dietary requirements or those who are insulin dependent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance metabolic health and potentially improve outcomes for patients with endometrial cancer.
How similar studies have performed: While the specific application of TRE in endometrial cancer is novel, similar dietary interventions have shown promise in other cancer populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Females aged 18 years or older * Diagnosed with endometrial cancer (any stage) * Clinically overweight or obese (BMI \>= 25 kg/m2) * At least 3 months post-cancer surgery and/or treatment * Weight stable for 3 months prior to beginning the study (\<4kg weight loss/gain) * Have a cell phone that is able to download a phone App and able to use phone during the day Exclusion Criteria: * Persons with special dietary requirements * Unable to provide informed consent * Unable to read, write, or fill in questionnaires in English * Insulin dependent diabetes * Night shift workers * Persons not able to use cell phone during day (like for work)
Where this trial is running
Salt Lake City, Utah
- Huntsman Cancer Institute — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Mary Playdon, PhD, MPH — University of Utah
- Study coordinator: Mary Playdon, PhD, MPH
- Email: mary.playdon@hci.utah.edu
- Phone: (801) 213-6264
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.